March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
A Randomized Controlled Trial of Vision Self-Monitoring Tools in Non-Neovascular Age-Related Macular Degeneration Subjects
Author Affiliations & Notes
  • Mark C. Roser
    Results Group, LLC, Hebron, Connecticut
  • Sheryl Torr-Brown
    Results Group, LLC, Hebron, Connecticut
  • Patricia Beaton
    Results Group, LLC, Hebron, Connecticut
  • Ava K. Bittner
    Ophthalmology, Johns Hopkins University, Baltimore, Maryland
  • Gislin Dagnelie
    Ophthal-Lions Vision Cntr, Johns Hopkins Univ, Baltimore, Maryland
  • Ellen Arnold
    Ophthalmology, Johns Hopkins University, Baltimore, Maryland
  • Footnotes
    Commercial Relationships  Mark C. Roser, 7,798,645 (P), Results Group LLC (E); Sheryl Torr-Brown, Results Group LLC (E); Patricia Beaton, Results Group LLC (E); Ava K. Bittner, None; Gislin Dagnelie, None; Ellen Arnold, None
  • Footnotes
    Support  NIH Grant EY018990-02
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 5180. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mark C. Roser, Sheryl Torr-Brown, Patricia Beaton, Ava K. Bittner, Gislin Dagnelie, Ellen Arnold; A Randomized Controlled Trial of Vision Self-Monitoring Tools in Non-Neovascular Age-Related Macular Degeneration Subjects. Invest. Ophthalmol. Vis. Sci. 2012;53(14):5180.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : A randomized controlled trial will evaluate the efficacy of an enhanced grid and interactive diary booklet developed to help patients with age-related macular degeneration (AMD) self-monitor their vision for changes.

Methods: : 70 subjects with AREDS grade 3 or 4, intermediate, non-neovascular AMD in at least one eye completed a 6 month follow-up questionnaire. 29 subjects were randomized at baseline to self-monitor their vision using the interactive diary booklet, and 41 were randomized to a standard of care control group and followed their doctor’s instructions for vision monitoring (e.g. Amsler grid).

Results: : There was a statistically significant difference in the proportion of subjects in each group who reported monitoring their vision at least weekly: 83% of the subjects with the interactive diary booklet vs. 46% of the control group (p=0.002). Subjects with the interactive diary booklet were significantly more likely to check their vision at least weekly: odds ratio (OR)=5.6; 95% CI: 1.8-17.4; p=0.003. Approximately one third of the controls (n=14; 34%) indicated that they had not checked their vision in the past 6 months, while none of the subjects with the interactive diary booklet reported that they did not check their vision. There was a highly statistically significant difference in self-monitoring confidence between the groups: only 17% of the subjects with the interactive diary booklet vs. 56% of the controls reported that they did not feel confident that they were taking care of their sight by monitoring their vision (p=0.001). Patients with previous neovascular AMD in the fellow eye (23%; n=16) were significantly more likely to monitor their vision at least weekly, after adjusting for their group assignment (OR=9; 95% CI: 2.0-40.5; p=0.004). Gender (p=0.25) was not a significant predictor of weekly vision monitoring.

Conclusions: : These findings support the preliminary efficacy of the interactive diary booklet for increasing vision self-monitoring behavior in AMD subjects. Continued research will help determine if the subjects can accurately detect true vision changes and self-refer for immediate evaluation by their eye care provider.

Clinical Trial: : http://www.clinicaltrials.gov NCT01337414

Keywords: age-related macular degeneration • clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×